NZ329959A - Treatment of human cellular abnormality by provoking cytolytic t cell response to cells presenting complexes of an mhc molecule and a tyrosinase derived peptide on their surfaces
- Google Patents
Treatment of human cellular abnormality by provoking cytolytic t cell response to cells presenting complexes of an mhc molecule and a tyrosinase derived peptide on their surfaces
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/203,054external-prioritypatent/US5530096A/en
Priority claimed from US08/233,305external-prioritypatent/US5519117A/en
Application filed by Ludwig Inst Cancer ResfiledCriticalLudwig Inst Cancer Res
Publication of NZ329959ApublicationCriticalpatent/NZ329959A/en
NZ329959A1994-02-281995-02-16Treatment of human cellular abnormality by provoking cytolytic t cell response to cells presenting complexes of an mhc molecule and a tyrosinase derived peptide on their surfaces
NZ329959A
(en)
Treatment of human cellular abnormality by provoking cytolytic t cell response to cells presenting complexes of an mhc molecule and a tyrosinase derived peptide on their surfaces
Treatment of human cellular abnormality by provoking cytolytic t cell response to cells presenting complexes of an mhc molecule and a tyrosinase derived peptide on their surfaces